Entod Pharma appoints Prof Vivek Padgaonkar as Non-Executive Independent Director

Prof. Padgaonkar brings a wealth of experience from his extensive work with various lobbying and think-tank organisations on healthcare issues. His collaborations with several government ministries have significantly shaped current pharmaceutical policies. He also holds independent directorships at Martin & Harris Labs Ltd., Bervin Investment & Leasing Limited, and Juvenor Healthcare.

Founded in 1977, ENTOD Pharmaceuticals is a research-driven Indian pharmaceutical company. The company operates in more than 67 countries.

Dr. Vivek Padgaonkar expressed his eagerness about joining the board, "I am honoured to join ENTOD Pharmaceuticals and contribute to its mission of driving innovation in the pharmaceutical industry. This is a remarkable opportunity to leverage my experience with a company at the forefront of technological advancements."

Nikkhil K. Masurkar, CEO of ENTOD Pharmaceuticals, commented on the appointment, "We are thrilled to welcome Prof. Padgaonkar to our board. His extensive experience and respected stature in the industry will be invaluable as we strive to position ENTOD and the Indian pharmaceutical sector as global leaders in innovation. His insights will be crucial in our ongoing efforts to develop novel solutions using advanced AI technologies, pushing our vision of a future-ready pharmaceutical industry."

Earlier this year, ENTOD Pharmaceuticals inaugurated its state-of-the-art research & development centre. The DSIR-approved research laboratory is equipped with the latest molecular and formulation research tools, microbiology testing facilities, sterile batch production capacity, and high-end quality assurance/quality control analytical equipment.